RNA-based biocatalysts, including ribozymes and CRISPR–Cas systems, promise transformative gene therapies through precise nucleic acid manipulation. This Comment highlights the key

mechanistic insights, therapeutic applications and challenges for clinical translation, offering the prospect of personalized medicine.